The purpose of the BE-WEL in CR-AF study is to develop and test a small-changes behavioural weight loss approach for patients with atrial fibrillation (AF) and obesity attending a cardiac rehabilitation program. This two-part study consists of (1) a qualitative investigation to explore barriers and facilitators to behavioural weight loss treatment among patients with AF and obesity, and (2) a randomized controlled trial to test whether patients who receive the behavioural weight loss component during their cardiac rehabilitation program, are more likely to lose 10% of their body weight than those who do cardiac rehab alone.
Recruitment for Part I is currently underway. Adults diagnosed with atrial fibrillation and a BMI of 30 kg/m2 or more are eligible to participate. If you meet these criteria and are interested in participating, please ask your cardiology healthcare team if you can be referred to this study.
If you have any questions, please contact behmed@ucalgary.ca.